Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors.
Duran I, Hotté SJ, Hirte H, Chen EX, MacLean M, Turner S, Duan L, Pond GR, Lathia C, Walsh S, Wright JJ, Dancey J, Siu LL.
Duran I, et al. Among authors: pond gr.
Clin Cancer Res. 2007 Aug 15;13(16):4849-57. doi: 10.1158/1078-0432.CCR-07-0382.
Clin Cancer Res. 2007.
PMID: 17699864
Clinical Trial.